Technical Analysis for IMNM - Immunome, Inc.

Grade Last Price % Change Price Change
F 13.71 -2.00% -0.28
IMNM closed down 2.0 percent on Thursday, July 18, 2024, on 50 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
Earnings due: Aug 7
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Overbought Stochastic Strength 0.00%
Fell Below 200 DMA Bearish -2.00%
Stochastic Sell Signal Bearish -2.00%
50 DMA Support Bullish -2.00%
Weak + Overbought Other -2.00%
Outside Day Range Expansion -2.00%
Overbought Stochastic Strength -2.00%
Upper Bollinger Band Touch Strength -2.00%
Gapped Down Weakness -2.00%

   Recent Intraday Alerts

Alert Time
Down 3% about 21 hours ago
Down 2 % about 21 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
Fell Below Previous Day's Low about 22 hours ago
Down 1% about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Tumor Cancer Immunotherapy Monoclonal Antibodies Monoclonal Antibody Antibody Glycoproteins Antigen Symphogen

Is IMNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

T

TraderMike 5 months ago

I was in the right place at the right time on this today. 🎉  I actually bought it yesterday after it made a (you guessed it) 
Non-ADX 1,2,3,4 Bullish
 signal the day before.  I sold half around 21 and am still holding the other half of the shares.  

0 Reply

View full discussion...

Indicators

Indicator Value
52 Week High 30.958
52 Week Low 6.13
Average Volume 1,007,833
200-Day Moving Average 14.57
50-Day Moving Average 13.94
20-Day Moving Average 12.62
10-Day Moving Average 13.18
Average True Range 0.84
RSI (14) 52.61
ADX 20.2
+DI 23.39
-DI 22.04
Chandelier Exit (Long, 3 ATRs) 12.46
Chandelier Exit (Short, 3 ATRs) 13.58
Upper Bollinger Bands 14.37
Lower Bollinger Band 10.87
Percent B (%b) 0.81
BandWidth 27.75
MACD Line -0.05
MACD Signal Line -0.37
MACD Histogram 0.3226
Fundamentals Value
Market Cap 617.34 Million
Num Shares 45 Million
EPS -1.80
Price-to-Earnings (P/E) Ratio -7.62
Price-to-Sales 105.68
Price-to-Book 174.08
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.15
Resistance 3 (R3) 15.17 14.72 14.91
Resistance 2 (R2) 14.72 14.35 14.71 14.83
Resistance 1 (R1) 14.21 14.12 13.99 14.19 14.75
Pivot Point 13.76 13.76 13.64 13.75 13.76
Support 1 (S1) 13.25 13.39 13.03 13.23 12.67
Support 2 (S2) 12.80 13.16 12.79 12.59
Support 3 (S3) 12.29 12.80 12.51
Support 4 (S4) 12.27